NOTE 8: — LOSS PER ORDINARY SHARE The following tables detail the number of shares and loss used in the computation of basic and diluted loss per share for the six-months ended June 30, 2025 and 2024: | | | | | | | Number of shares | | | For the period of | | | six months ended | | | June 30, | | | 2025 | | 2024 | | | (unaudited) | | (unaudited) | Weighted number of Ordinary shares(*) | | 50,084,401 | | 48,057,015 |
| | | | | | | | | For the period of | | | six months ended | | | June 30, | | | 2025 | | 2024 | | | (unaudited) | | (unaudited) | Loss attributed to holders of Ordinary shares | | $ | 8,777 | | $ | 9,930 |
| (*) | The computation of diluted loss per share did not take into account potential Ordinary shares (detailed below) due to their anti-dilutive effect: |
| a. | 6,476,515 and 5,609,169 shares underlying equity incentive grants to employees, directors and consultants outstanding as of June 30, 2025 and 2024, respectively, under the Company’s share-based compensation plan. |
| b. | 14,850,000 Warrants outstanding as of each of June 30, 2025 and 2024. |
| c. | 99,303 Ordinary shares that were issued as part of the acquisition of Shipsta and are subject to certain restrictions, which were retained for customary holdbacks and net working capital adjustment. |
|